Brief: Adial Pharmaceuticals Announces Completion Of Last Patient, Last Visit In Its Phase 3 Trial Of Ad04
Feb 24 (Reuters) - Adial Pharmaceuticals Inc ADIL.O :
* ADIAL PHARMACEUTICALS ANNOUNCES COMPLETION OF LAST
PATIENT, LAST
VISIT IN ITS ONWARD™ PHASE 3 TRIAL OF AD04 FOR THE TREATMENT OF
PATIENTS WITH ALCOHOL USE DISORDER
Source text for Eikon: ID:nGNX6MZyPr
Further company coverage: ADIL.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Adial Pharmaceuticals
See all newsBrief: Adial Pharmaceuticals Announces Name Change To Azora Therapeutics
Brief: Adial Pharmaceuticals Announces Planned Appointment Of Celia Economides As Chief Financial Officer
Brief: Adial Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
Brief: Adial Pharmaceuticals - Proposed Resale Of Up To 25,148,970 Shares Of Common Stock By Selling Stockholders - SEC Filing
Brief: Adial Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)